Affinage

VPS9D1

VPS9 domain-containing protein 1 · UniProt Q9Y2B5

Length
631 aa
Mass
69.0 kDa
Annotated
2026-06-11
29 papers in source corpus 2 papers cited in narrative 2 extracted findings
Cross-family judge faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

VPS9D1 is a VPS9-domain-containing guanine-nucleotide-exchange factor that regulates membrane trafficking through the clathrin-independent endocytic pathway (PMID:36762583). It acts as a GEF specifically for Rab22A but not Rab5A, and through this activity drives the formation of tubular endosomes: depletion of VPS9D1 in HeLa cells severely impairs tubular endosome formation, a defect rescued by constitutively active Rab22A but not by a GEF-activity-deficient VPS9D1 mutant (PMID:36762583). Consistent with a role in this pathway, loss of VPS9D1 alters the distribution of clathrin-independent endocytic cargos and impairs their recycling (PMID:36762583). The protein was originally cloned as ATP-BL, encoding a 438-residue product with a coiled-coil motif and limited regional homology to the bacterial ATP synthase b subunit, and mapped to chromosome 16q24 (PMID:10231027). Beyond its Rab22A GEF activity and role in tubular endosome biogenesis, no further mechanistic detail has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 2 steps
  1. 1999 Medium

    Established the existence and primary sequence of the gene by isolating its cDNA, providing the molecular starting point before any function was known.

    Evidence cDNA cloning from a human leukocyte library with sequence homology analysis and chromosomal mapping by FISH and radiation hybrid mapping

    PMID:10231027

    Open questions at the time
    • The regional homology to bacterial ATP synthase b subunit was never confirmed by a functional ATP synthase assay
    • No cellular function or localization was assigned
    • The significance of the predicted coiled-coil motif was not tested
  2. 2023 High

    Defined VPS9D1 as a Rab-specific GEF and connected it to a discrete trafficking step, answering what the protein actually does in cells.

    Evidence siRNA depletion, dominant-active Rab22A rescue, GEF-dead mutant rescue, and cargo trafficking assays in HeLa cells

    PMID:36762583

    Open questions at the time
    • No in vitro reconstitution of GEF kinetics on purified Rab22A
    • No structural basis for Rab22A specificity over Rab5A
    • Upstream signals and recruitment mechanism to tubular endosomes not defined

Open questions

Synthesis pass · forward-looking unresolved questions
  • How VPS9D1 is recruited to and activated at the tubular endosome, and whether it has functions outside the clathrin-independent endocytic pathway, remain open.
  • No interactome or upstream regulators identified
  • Function tested only in HeLa cells
  • Physiological/organismal role unexplored

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 1
Localization
GO:0005768 endosome 1
Pathway
R-HSA-5653656 Vesicle-mediated transport 1
Partners

Evidence

Reading pass · 2 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1999 VPS9D1 (ATP-BL) was cloned from a human leukocyte cDNA library and found to encode a 438-amino-acid protein with 37.9% identity to the b subunit of bacterial ATP synthase over a 57-amino-acid region, and contains a predicted coiled-coil motif. The locus was mapped by FISH and radiation hybrid mapping to chromosome 16q24. cDNA cloning, sequence homology analysis, FISH, radiation hybrid mapping DNA research : an international journal for rapid publication of reports on genes and genomes Medium 10231027
2023 VPS9D1 acts as a guanine-nucleotide-exchange factor (GEF) specifically for Rab22A but not Rab5A. Depletion of Vps9d1 in HeLa cells severely impaired tubular endosome formation without affecting Rab5A localization. Expression of a constitutively active Rab22A mutant rescued tubular endosomes in Vps9d1-depleted cells, but a GEF-activity-deficient Vps9d1 mutant did not. Vps9d1 depletion also altered distribution of clathrin-independent endocytosed cargos and impaired their recycling. siRNA depletion, fluorescence microscopy, rescue with constitutively active Rab22A mutant and GEF-activity-deficient Vps9d1 mutant, cargo trafficking assays in HeLa cells Journal of cell science High 36762583

Source papers

Stage 0 corpus · 29 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2017 Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. Cancer biomarkers : section A of Disease markers 49 29036784
2019 ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 41 31918265
2022 VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8+ T cell killing in colorectal cancer. eLife 27 36458816
2020 LncRNA VPS9D1-AS1 promotes cell proliferation in acute lymphoblastic leukemia through modulating GPX1 expression by miR-491-5p and miR-214-3p evasion. Bioscience reports 27 32808668
2020 Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway. Frontiers in pharmacology 26 33192510
2020 Long noncoding RNA VPS9D1-AS1 augments the malignant phenotype of non-small cell lung cancer by sponging microRNA-532-3p and thereby enhancing HMGA2 expression. Aging 24 31902794
2021 Long non-coding RNA VPS9D1-AS1 facilitates cell proliferation, migration and stemness in hepatocellular carcinoma. Cancer cell international 21 33627127
2021 Long noncoding RNA VPS9D1-AS1 promotes esophageal squamous cell carcinoma progression via the Wnt/β-catenin signaling pathway. Journal of Cancer 19 34659577
2022 LncRNA VPS9D1-AS1 Promotes Malignant Progression of Lung Adenocarcinoma by Targeting miRNA-30a-5p/KIF11 Axis. Frontiers in genetics 18 35140744
2021 The lncRNA VPS9D1-AS1 Promotes Hepatocellular Carcinoma Cell Cycle Progression by Regulating the HuR/CDK4 Axis. DNA and cell biology 16 34558987
2020 Long Noncoding RNA VPS9D1-AS1 Sequesters microRNA-525-5p to Promote the Oncogenicity of Colorectal Cancer Cells by Upregulating HMGA1. Cancer management and research 16 33116849
2022 Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1. The Kaohsiung journal of medical sciences 13 36245426
2025 VPS9D1-AS1 antisense therapy via lipid nanoparticles reprograms cold tumors and enhances immunotherapy in colorectal cancer. Journal of controlled release : official journal of the Controlled Release Society 10 40412657
2022 VPS9D1-AS1, a novel long-non-coding RNA, acts as a tumor promoter by regulating the miR-324-5p/ITGA2 axis in colon adenocarcinoma. American journal of translational research 8 35273698
2019 Analysis of overlapping heterozygous novel submicroscopic CNVs and FANCA-VPS9D1 fusion transcripts in a Fanconi anemia patient. Journal of human genetics 8 31239491
2024 Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis. Environmental toxicology 7 38953363
2023 LncRNA VPS9D1-AS1 regulates miR-187-3p/fibroblast growth factor receptor-like 1 axis to promote proliferation, migration, and invasion of prostate cancer cells. The Chinese journal of physiology 7 37929340
2021 Long non-coding RNA VPS9D1-AS1 promotes growth of colon adenocarcinoma by sponging miR-1301-3p and CLDN1. Human cell 7 34519940
2023 Vps9d1 regulates tubular endosome formation through specific activation of Rab22A. Journal of cell science 6 36762583
2022 VPS9D1-AS1 gene rs7206570 polymorphism associated with the clinical stage of colorectal cancer and binding with hsa-miR-361-3p. Human cell 6 35022999
2022 LncRNA VPS9D1-AS1 Sponging miR-520a-5p Contributes to the Development of Uterine Corpus Endometrial Carcinoma by Enhancing BIRC5 Expression. Molecular biotechnology 6 35619019
2025 Plasma expression of antisense LncRNAs RBM5-AS1, VPS9D1-AS1 and STEAP3-AS1 as novel biomarkers for colorectal cancer diagnosis. Molecular biology reports 4 40522493
1999 Isolation and mapping of a putative b subunit of human ATP synthase (ATP-BL) from human leukocytes. DNA research : an international journal for rapid publication of reports on genes and genomes 3 10231027
2025 VPS9D1-AS1: a critical oncogenic long non-coding RNA in human malignancies. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2 41460448
2025 Long noncoding RNA VPS9D1-AS1 promotes angiogenesis in colorectal cancer by regulating the VEGFA signalling pathway. American journal of cancer research 1 40371141
2026 Long Non-Coding RNA VPS9D1-AS1 in Human Cancer: Functions, Mechanisms, and Clinical Utility. Anti-cancer agents in medicinal chemistry 0 40908689
2026 Emergence and Tandem Repeat-Mediated Elongation of a Translated De Novo Open Reading Frame in Human Oncogenic RNA Gene VPS9D1-AS1 (MYU). Genome biology and evolution 0 41527363
2025 Exosomal transfer of VPS9D1-AS1 induces M2 polarization to promote erlotinib resistance of LUAD cells via activation of the Wnt/β-catenin signaling pathway. Biochemical pharmacology 0 41207568
2023 Long Noncoding RNA VPS9D1-AS1 Sequesters microRNA-525-5p to Promote the Oncogenicity of Colorectal Cancer Cells by Upregulating HMGA1 [Retraction]. Cancer management and research 0 37469373

Missed literature

Know a paper Affinage missed for VPS9D1? Flag it for the maintainers and the community.

No submissions yet.